Xiaoding Xu

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Oxidative Stress

Top Venues

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Accounts of chemical research

This page only lists publications with an associated author ORCID identifier.

Publications

Rui Xu, Xiangya Liu, Yuxuan Zhang, Guo Wu, Linzhuo Huang, Rong Li, Xiaoding Xu
Antibody-Decorated Nanoplatform to Reprogram Macrophage and Block Immune Checkpoint LSECtin for Effective Cancer Immunotherapy. Nano letters (2024)
Rui Xu, Xiangya Liu, Yuxuan Zhang, Guo Wu, Linzhuo Huang, Rong Li, Xiaoding Xu
Antibody-Decorated Nanoplatform to Reprogram Macrophage and Block Immune Checkpoint LSECtin for Effective Cancer Immunotherapy. Nano letters 24 (28) (2024)
Lei Xu, Yuan Cao, Ya Xu, Rong Li, Xiaoding Xu
Redox-Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities and Challenges. Macromolecular bioscience (2023)
Rui Xu, Linzhuo Huang, Jiayu Liu, Yuxuan Zhang, Ya Xu, Rong Li, Shicheng Su, Xiaoding Xu
Remodeling of Mitochondrial Metabolism by a Mitochondria-Targeted RNAi Nanoplatform for Effective Cancer Therapy. Small (Weinheim an der Bergstrasse, Germany) (2023)
Senlin Li, Lei Xu, Guo Wu, Ziqi Huang, Linzhuo Huang, Fengqian Zhang, Chunfang Wei, Qian Shen, Rong Li, Lei Zhang, Xiaoding Xu
Remodeling Serine Synthesis and Metabolism via Nanoparticles (NPs)-Mediated CFL1 Silencing to Enhance the Sensitivity of Hepatocellular Carcinoma to Sorafenib. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Ying Xu, Wei Ren, Qingjian Li, Chaohui Duan, Xiaorong Lin, Zhuo-Fei Bi, Kaiyun You, Qian Hu, Ning Xie, Yunfang Yu, Xiaoding Xu, Hai Hu, Herui Yao
LncRNA Uc003xsl.1-Mediated Activation of the NFκB/IL8 Axis Promotes Progression of Triple-Negative Breast Cancer. Cancer research 82 (4) (2022)
Zixian Huang, Shaomin Liu, Nan Lu, Lei Xu, Qian Shen, Zhuoshan Huang, Zhiquan Huang, Phei Er Saw, Xiaoding Xu
Nucleus-specific RNAi nanoplatform for targeted regulation of nuclear lncRNA function and effective cancer therapy. Exploration (Beijing, China) 2 (5) (2022)
Xiwang Yang, Ya Wen, Shaomin Liu, Liqiang Duan, Tongfeng Liu, Zhou Tong, Zhuo Wang, Yinmin Gu, Yibo Xi, Xiaodong Wang, Dingsan Luo, Ruobing Zhang, Yajuan Liu, Yang Wang, Tianyou Cheng, Siyuan Jiang, Xiaofeng Zhu, Xiaohui Yang, Yongbo Pan, Shuwen Cheng, Qinong Ye, Jinfei Chen, Xiaoding Xu, Shan Gao
LCDR regulates the integrity of lysosomal membrane by hnRNP K-stabilized LAPTM5 transcript and promotes cell survival. Proceedings of the National Academy of Sciences of the United States of America 119 (5) (2022)
Phei Er Saw, Xiaoding Xu, Sunghyun Kim, Sangyong Jon
Biomedical Applications of a Novel Class of High-Affinity Peptides. Accounts of chemical research 54 (18) (2021)
Yuxi Zhang, Zhenghai Zhang, Senlin Li, Liang Zhao, Dongdong Li, Ziyang Cao, Xiaoding Xu, Xian-Zhu Yang
A siRNA-Assisted Assembly Strategy to Simultaneously Suppress "Self" and Upregulate "Eat-Me" Signals for Nanoenabled Chemo-Immunotherapy. ACS nano 15 (10) (2021)
Lei Xu, Rui Xu, Phei Er Saw, Jun Wu, Si-Xue Cheng, Xiaoding Xu
Nanoparticle-Mediated Inhibition of Mitochondrial Glutaminolysis to Amplify Oxidative Stress for Combination Cancer Therapy. Nano letters 21 (18) (2021)
Zhuofei Bi, Qingjian Li, Xiaoxiao Dinglin, Ying Xu, Kaiyun You, Huangming Hong, Qian Hu, Wei Zhang, Chenchen Li, Yujie Tan, Ning Xie, Wei Ren, Chuping Li, Yimin Liu, Hai Hu, Xiaoding Xu, Herui Yao
Nanoparticles (NPs)-Meditated LncRNA AFAP1-AS1 Silencing to Block Wnt/β-Catenin Signaling Pathway for Synergistic Reversal of Radioresistance and Effective Cancer Radiotherapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 7 (18) (2020)
Yujing Li, Jian-Xun Ding, Xiaoding Xu, Run Shi, Phei Er Saw, Junqing Wang, Shirley Chung, Wenliang Li, Bader M Aljaeid, Robert J Lee, Wei Tao, Lesheng Teng, Omid C Farokhzad, Jin-Jun Shi
Dual Hypoxia-Targeting RNAi Nanomedicine for Precision Cancer Therapy. Nano letters 20 (7) (2020)
Phei Er Saw, Herui Yao, Chunhao Lin, Wei Tao, Omid C Farokhzad, Xiaoding Xu
Stimuli-Responsive Polymer-Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy. Nano letters 19 (9) (2019)
Wei Jiang, Quan Li, Liang Xiao, Jiaxiang Dou, Yi Liu, Wenhao Yu, Yinchu Ma, Xiaoqiu Li, Ya-Qi Zhu, Zhuting Tong, Hang Liu, Hui Liang, Ligong Lu, Xiaoding Xu, Yandan Yao, Guoqing Zhang, Yu-Cai Wang, Jun Wang
Hierarchical Multiplexing Nanodroplets for Imaging-Guided Cancer Radiotherapy via DNA Damage Enhancement and Concomitant DNA Repair Prevention. ACS nano 12 (6) (2018)